Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Pgb2
1. 13367-85-6
2. Pgb2
3. Pgb2 (prostaglandin B2)
4. Biu61o9t9t
5. Chebi:28099
6. (z)-7-[2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic Acid
7. 15s-hydroxy-9-oxo-5z,8(12),13e-prostatrienoic Acid
8. Prosta-5,8(12),13-trien-1-oic Acid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
9. Prosta-5,8(12),13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
10. Unii-biu61o9t9t
11. Prosta-glandinb2
12. Bspbio_001484
13. Bml1-f04
14. Schembl3368055
15. Eicosanoids_pgb2_c20h30o4
16. Chembl1901620
17. Bcbcmap01_000173
18. Dtxsid50864391
19. Hms1361k06
20. Hms1791k06
21. Hms1989k06
22. Hms3402k06
23. Hms3648k17
24. Zinc4521814
25. Lmfa03010018
26. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oic Acid
27. Prostaglandin B2, >=98%, Synthetic
28. Db02304
29. Idi1_033954
30. Ncgc00161283-01
31. Ncgc00161283-02
32. Ncgc00161283-03
33. Dinoprostone Impurity E [ep Impurity]
34. C05954
35. Sr-01000946234
36. J-006426
37. Sr-01000946234-1
38. Brd-k82865713-001-02-6
39. Q27093323
40. 15-hydroxy-9-oxoprosta-5,8(12),13-trienoic Acid
41. 15.alpha.-hydroxy-9-ketoprosta-5,8(12),13-trienoic Acid
42. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 8(12),13-trien-1-oic Acid
43. (z)-7-(2-((e)-(3s)-3-hydroxyoct-1-enyl)-5-oxocyclopent-1-enyl)hept-5-enoic Acid
44. (z)-7-[2-[(e,3r)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic Acid
45. Dinoprostone Impurity, (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 8(12),13-trien-1-oic Acid- [usp Impurity]
| Molecular Weight | 334.4 g/mol |
|---|---|
| Molecular Formula | C20H30O4 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 12 |
| Exact Mass | 334.21440943 g/mol |
| Monoisotopic Mass | 334.21440943 g/mol |
| Topological Polar Surface Area | 74.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 500 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Prostaglandin B2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prostaglandin B2, including repackagers and relabelers. The FDA regulates Prostaglandin B2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prostaglandin B2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prostaglandin B2 supplier is an individual or a company that provides Prostaglandin B2 active pharmaceutical ingredient (API) or Prostaglandin B2 finished formulations upon request. The Prostaglandin B2 suppliers may include Prostaglandin B2 API manufacturers, exporters, distributors and traders.
Prostaglandin B2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prostaglandin B2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prostaglandin B2 GMP manufacturer or Prostaglandin B2 GMP API supplier for your needs.
A Prostaglandin B2 CoA (Certificate of Analysis) is a formal document that attests to Prostaglandin B2's compliance with Prostaglandin B2 specifications and serves as a tool for batch-level quality control.
Prostaglandin B2 CoA mostly includes findings from lab analyses of a specific batch. For each Prostaglandin B2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prostaglandin B2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Prostaglandin B2 EP), Prostaglandin B2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prostaglandin B2 USP).
LOOKING FOR A SUPPLIER?
